Variant report
Variant | nsv1030462 |
---|---|
Chromosome Location | chr8:115227867-115250916 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560096475 | chr8:115229632-115229633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117159604 | chr8:115229648-115229649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17631764 | chr8:115229697-115229698 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs181238464 | chr8:115229718-115229719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs16885580 | chr8:115229759-115229760 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs550226529 | chr8:115229790-115229791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571743067 | chr8:115229814-115229815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532670486 | chr8:115229841-115229842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186744005 | chr8:115229879-115229880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566137574 | chr8:115229940-115229941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536890825 | chr8:115229978-115229979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548585424 | chr8:115230013-115230014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188057514 | chr8:115230053-115230054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376127012 | chr8:115230085-115230086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs180961428 | chr8:115230122-115230123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144639117 | chr8:115230160-115230161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146697062 | chr8:115230224-115230225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148863658 | chr8:115230256-115230257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374589832 | chr8:115230314-115230315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572140254 | chr8:115230349-115230350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542844541 | chr8:115230378-115230379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558133369 | chr8:115230394-115230395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545568802 | chr8:115230482-115230483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143576570 | chr8:115230521-115230522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543805279 | chr8:115230551-115230552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565291418 | chr8:115230555-115230556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148058720 | chr8:115230562-115230563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547563110 | chr8:115230563-115230564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559831966 | chr8:115230602-115230603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185149889 | chr8:115230611-115230612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530210111 | chr8:115230684-115230685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17704523 | chr8:115230720-115230721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17631819 | chr8:115230793-115230794 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs537356168 | chr8:115230839-115230840 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571310474 | chr8:115230845-115230846 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114244879 | chr8:115230860-115230861 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538670297 | chr8:115230874-115230875 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141807050 | chr8:115230880-115230881 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534093817 | chr8:115230883-115230884 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572137325 | chr8:115230888-115230889 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17631843 | chr8:115230950-115230951 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs563745734 | chr8:115230976-115230977 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572558255 | chr8:115243227-115243228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533642145 | chr8:115243254-115243255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192294458 | chr8:115243256-115243257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573730309 | chr8:115243260-115243261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544415556 | chr8:115243267-115243268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372010694 | chr8:115243300-115243301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562605703 | chr8:115243310-115243311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577875786 | chr8:115243321-115243322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115229600-115230800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:115230400-115231000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr8:115230800-115231000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr8:115243200-115252800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr8:115248600-115249200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:115249000-115249600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr8:115249000-115252600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
8 | chr8:115249600-115252800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |